Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Watkins

Showing results (311-320 of 320) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 320 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a <i>BRCA1</i> or <i>BRCA2</i> Gene AlterationWassim Abida, Akash Patnaik, David Campbell, et al.
The New England Journal of Medicine|February 16, 2023
Rucaparib or Physician's Choice in Metastatic Prostate CancerKarim Fizazi, Josep M Piulats, M Neil Reaume, et al.
European Urology|June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 StudyWassim Abida, David Campbell, Akash Patnaik, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Blood Advances|March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell LymphomaEdward R Scheffer Cliff, Guido D Pelaez, Fei Wan, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Blood Advances|May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
BMJ Open|January 8, 2026
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) trial: a protocol for a pragmatic randomised study of diverticulitis treatment in the USAMariam N Hantouli, Robert H Schmicker, Janice E Tufte, et al.
Blood Advances|February 23, 2022
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphomaJuan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, et al.
Pageof 32

Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a <i>BRCA1</i> or <i>BRCA2</i> Gene AlterationWassim Abida, Akash Patnaik, David Campbell, et al.
The New England Journal of Medicine|February 16, 2023
Rucaparib or Physician's Choice in Metastatic Prostate CancerKarim Fizazi, Josep M Piulats, M Neil Reaume, et al.
European Urology|June 5, 2023
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 StudyWassim Abida, David Campbell, Akash Patnaik, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 30, 2022
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World ExperienceMuhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, et al.
Blood Advances|March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell LymphomaEdward R Scheffer Cliff, Guido D Pelaez, Fei Wan, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Blood Advances|May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
BMJ Open|January 8, 2026
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) trial: a protocol for a pragmatic randomised study of diverticulitis treatment in the USAMariam N Hantouli, Robert H Schmicker, Janice E Tufte, et al.
Blood Advances|February 23, 2022
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphomaJuan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, et al.
Pageof 32